Search Results for " Afatinib "
Afatinib Related Products
Afatinib is a medication used to treat non-small cell lung carcinoma (NSCLC). It belongs to the tyrosine kinase inhibitor family of medications. Afatinib is being investigated as a monotherapy for individuals with HER2-positive breast cancer who have experienced progression despite management with trastuzumab.
SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Afatinib, pharmacopeial and non-pharmacopeial Afatinib impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Afatinib impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.
Afatinib-related products are thoroughly characterized. Afatinib products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.